Sujal. Thanks,
seriously progress philosophy was against of The of number We our our I our to take for and openness quarter that with both the to community. and put solid QX processes to scientific our highlighted goals, that great into continued always operate innovations of consumables pleased increased very with was number opportunities an development opportunities first and maturation transparency, share commitment the provided our appropriate instruments, scientific a practice. and by really
from share us example, March. For I excited the Proteome results important our with Genentech at Organization, in of was the chance Human HUPO, to the collaboration have arm to US
was event potential to I molecule the of the and great that Association, Our impact attention afterwards. detection afterwards, also at proteomic presented received, memorable a questions. single European and a talk development researchers, was Since that of poster Annual came the analysis single attendees, drew of biology tau of platform conversations when house I of molecule significant the EuPA. to the Proteomics a led high-value several a itself was well to from titled, packed on our gratified came moment phosphorylation, a at these Congress novel particularly our The technology. throughout his the from validation researcher HUPO, presentation our like presentation. happens the team isoform-specific inundated represent hundred single and of view molecule with shared level. well-known me One and number customers, Sentiments with interest future
mind. a one before ask hear While never for respected questions It proteomics a user, biology-focused how fantastic suggested his I to platform, ever a investigate he conversations of me complement might German traditional a to than possible. different the serve attendees platform I out that one Immediately methods. EuPA, of had with creative the recommendations crossed Nautilus leveraging to following and ones many highly enable of Nautilus of had was talk, to with discussion and a number even exciting to at After valuable potential power really me. event, our fundamentally researcher. had as really platform, analysis could the applications workflows, to Frankly, number a stood see and that the use were his my researchers my wrote
meetings, proteomics. sign spectrometric come, influential with I things tremendous presentation EuPA mass believe good with for has heavy a is of on to for a going and use critically proteomics positive was received, more platform Nautilus buying our the As the and to attention methods audience. in The important many spur that this the now innovation community. than creativity ever proteomic focus broader
presented of Development, meeting Applications addition opportunities, Kapp, Association Greg American poster single Dr. Research’s our annual of In at a molecule approach. Cancer on the Associate our those Director to
and many medicines demonstrate today. validates produce tetramer internal our were recognized When data ability antibodies our were That than class demonstrates presentation, clearly that part the a In not of shared antibodies because of that typically antibodies. protein-specific. magnitude hypothesis is the orders we bind AACR platform, targets novel to these stronger that strong antibodies trimer our the of in correct, results binding, challenges addition, built not associated internal Picomolar we This with for conceived development build at we they as of to used incredibly was ability and creating that teams of to ECXXs. the first peptide time, the therapeutic that
dense focus enabling two single to that protein Archive. on instrument teams. a protein The are deposit occupancy Using there number and and scalable billion of Bio molecule to important taking now breakthrough massively arrays innovative of creation way involves molecules protein saw nanostructures, software, process single single thus hyperdense, where between we molecule the in enables closely almost pad molecule XX both orchestrated an collaborations that completely based that pad, manuscript, a and our studies, our for while achieves co-localizations. on build single sensitivity of arrays, commercial wide pads of a important high-quality, as Critical integration, engineering, and allow across The ability range. of high to high-speed concept demonstrated on single limiting continued never ability important dynamic single analysis that hyperdense nano-fabricated that This and create molecule describing our is achievement, is our our on this our commercial is array. hyperdense to samples use, as highly simultaneously to Another platform, single over arrays, scientific XX%, proteins landing cornerstone protein complex detection advancing instrument. DNA chip protein uniformly applications parallel technology and phases on available identification. of QX from possible are proprietary the
continue manufacturing We successfully to commercial full as posture to towards availability. transition a we build
to just Affinity Development, Reagent Before to Dr. about a financials, our moment turn want our bit over tell President Wilcox. little Anna Sheri you to I of review more things a to Vice I take new
development even the an For various Nautilus from as of here with in Sheri recently to where those who renowned of already most Engagement. comes where was might not Director she served impact in presence is a at of scientist, be Senior Nautilus, her days Global aware, protein time products, early and making us. the Scientific SomaLogic, She's instrumental whose she
hand on I'll are to to We team. very the excited have that, call our over all With her Anna.
